Skip to main content

Association between pathologic gambling and parkinsonian therapy as detected in the Food and Drug Administration Adverse Event database.

Publication ,  Journal Article
Szarfman, A; Doraiswamy, PM; Tonning, JM; Levine, JG
Published in: Arch Neurol
February 2006

Duke Scholars

Published In

Arch Neurol

DOI

ISSN

0003-9942

Publication Date

February 2006

Volume

63

Issue

2

Start / End Page

299 / 300

Location

United States

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Reproducibility of Results
  • Parkinson Disease
  • Neurology & Neurosurgery
  • Levodopa
  • Humans
  • Gambling
  • Databases, Factual
  • Antiparkinson Agents
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Szarfman, A., Doraiswamy, P. M., Tonning, J. M., & Levine, J. G. (2006). Association between pathologic gambling and parkinsonian therapy as detected in the Food and Drug Administration Adverse Event database. Arch Neurol, 63(2), 299–300. https://doi.org/10.1001/archneur.63.2.299-b
Szarfman, Ana, P Murali Doraiswamy, Joseph M. Tonning, and Jonathan G. Levine. “Association between pathologic gambling and parkinsonian therapy as detected in the Food and Drug Administration Adverse Event database.Arch Neurol 63, no. 2 (February 2006): 299–300. https://doi.org/10.1001/archneur.63.2.299-b.
Szarfman, Ana, et al. “Association between pathologic gambling and parkinsonian therapy as detected in the Food and Drug Administration Adverse Event database.Arch Neurol, vol. 63, no. 2, Feb. 2006, pp. 299–300. Pubmed, doi:10.1001/archneur.63.2.299-b.

Published In

Arch Neurol

DOI

ISSN

0003-9942

Publication Date

February 2006

Volume

63

Issue

2

Start / End Page

299 / 300

Location

United States

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Reproducibility of Results
  • Parkinson Disease
  • Neurology & Neurosurgery
  • Levodopa
  • Humans
  • Gambling
  • Databases, Factual
  • Antiparkinson Agents